Brentwood, TN
Praxis a company specializing in centralized patient recruitment and retention for clinical research studies, will provide patient recruitment services to a top pharmaceutical company for a study on pediatric epilepsy. This study explores a drug’s effectiveness in very young children. Praxis’ experiences with hard to reach and specialized patient populations is extensive and includes a number of pediatric trials.
Praxis’ successful experiences with hard to reach and specialized patient populations is extensive, and includes a number of pediatric trials. Praxis has helped sponsors successfully enroll pediatric studies:
on average 2 months ahead of schedule
with retention rates most often at 96%, and
with sponsors achieving ROI from ~$1M to ~$3M
“Any time we create and manage a trial involving children there is a real added focus on understanding the mother’s perspective and concerns. We seek to really connect with the mother through images and words that speak to the heart. And by providing content that educates and informs the mom about options, the indication, and the medical research study at hand.” Donna Beasley, VP of operations.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo
January 17th 2025Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a comparable safety and tolerability profile, further establishing its efficacy in obesity treatment.